Page results
-
What does the staff experience team do? The Staff Experience team brings many amazing initiatives to our hardworking teams across UCLH. We’ve delivered the Be Well programme to support health…
-
Introduction This patient information leaflet is for patients who are doing a breath test at home. Please read it carefully before you start your test. Please complete your test within the next two…
-
Introduction This patient information page is for patients who are doing a breath test at home. Please read it carefully before you start your test. Please complete your test within the next two…
-
The purpose of this information is to: Describe what a pregnancy of unknown location (PUL) is. Discuss what it means for your pregnancy and your health. Explain what we do to locate the pregnancy…
-
This page has been written by the Department of Neuroradiology at the National Hospital for Neurology and Neurosurgery (NHNN). Our aim is to provide you with information about endovascular treatments…
-
Who are we and what do we do? We are a therapies team comprising of Physiotherapists, Occupational Therapists and Speech and Language Therapists. We see people with neurological conditions who…
-
November is men’s health month (Movember), we are hosting our first public Live Q&A event via MS Teams.
-
The support and information specialists were shortlisted for a self-care innovation award. The award recognises the achievements of the team in developing and delivering a package of support for…
File results
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events